Skip to main content
SpringerLink
Log in
Book cover

Bronchial Asthma pp 361–381Cite as

How Drugs Including Recreational Drugs Affect Asthma

  • Chapter
  • First Online:

  • 1918 Accesses

Abstract

Various drug and chemical exposures are associated with adverse effects on airways. These effects may induce or worsen the symptoms of asthma. The mechanisms of these airway changes vary from direct effects on receptors to immunologically mediated alterations.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Leuppi, J.D., et al., Drug-induced bronchospasm: analysis of 187 spontaneously reported cases. Respiration, 2001. 68(4): p. 345–51.

    CAS  PubMed  Google Scholar 

  2. Babu, K.S. and B.G. Marshall, Drug-induced airway diseases. Clin Chest Med, 2004. 25(1): p. 113–22.

    PubMed  Google Scholar 

  3. Lunde, H., et al., Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ, 1994. 308(6920): p. 18–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Wood, R., Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. Br J Clin Pharmacol, 1995. 39(3): p. 265–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Dykewicz, M.S., Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management. Curr Opin Allergy Clin Immunol, 2004. 4(4): p. 267–70.

    CAS  PubMed  Google Scholar 

  6. Kim, S.H. and H.S. Park, Pathogenesis of nonsteroidal antiinflammatory drug-induced asthma. Curr Opin Allergy Clin Immunol, 2006. 6(1): p. 17–22.

    CAS  PubMed  Google Scholar 

  7. Martin-Garcia, C., et al., Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest, 2002. 121(6): p. 1812–7.

    CAS  PubMed  Google Scholar 

  8. Kashiwabara, K. and H. Nakamura, Analgesic-induced asthma caused by 2.0% ketoprofen adhesive agents, but not by 0.3% agents. Intern Med, 2001. 40(2): p. 124–6.

    CAS  PubMed  Google Scholar 

  9. El Miedany, Y., et al., Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol, 2006. 97(1): p. 105–9.

    CAS  PubMed  Google Scholar 

  10. Ruffin, R.E., et al., Assessment of beta-adrenoceptor antagonists in asthmatic patients. Br J Clin Pharmacol, 1982. 13(Suppl 2): p. 325 S-335 S.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Hanania, N.A., et al., The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther, 2008. 21(1): p. 134–41.

    CAS  PubMed  Google Scholar 

  12. Salpeter, S.R., T.M. Ormiston, and E.E. Salpeter, Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med, 2002. 137(9): p. 715–25.

    CAS  PubMed  Google Scholar 

  13. Dickey, B.F., et al., beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol, 2010. 10(3): p. 254–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Bond, R.A., et al., Getting to the heart of asthma: can “beta blockers” be useful to treat asthma? Pharmacol Ther, 2007. 115(3): p. 360–74.

    CAS  PubMed  Google Scholar 

  15. Hanania, N.A., B.F. Dickey, and R.A. Bond, Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med, 2010. 16(1): p. 1–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Lipworth, B.J. and P.A. Williamson, Beta blockers for asthma: a double-edged sword. Lancet, 2009. 373(9658): p. 104–5.

    PubMed  Google Scholar 

  17. Grembiale, R.D., et al., Bronchial asthma induced by an antithyroid drug. Chest, 2001. 119(5): p. 1598–9.

    CAS  PubMed  Google Scholar 

  18. Nguyen, L.T. and K.V. Luong, Propylthiouracil-induced asthma. Allergy, 2004. 59(8): p. 889–90.

    CAS  PubMed  Google Scholar 

  19. Luong, K.V. and L.T. Nguyen, Hyperthyroidism and asthma. J Asthma, 2000. 37(2): p. 125–30.

    CAS  PubMed  Google Scholar 

  20. Nakazawa, T. and S. Kobayashi, Influence of antithyroidal therapy on asthma symptoms in the patients with both bronchial asthma and hyperthyroidism. J Asthma, 1991. 28(2): p. 109–16.

    CAS  PubMed  Google Scholar 

  21. Eneli, I., et al., Acetaminophen and the risk of asthma: the epidemiologic and pathophysiologic ­evidence. Chest, 2005. 127(2): p. 604–12.

    PubMed  Google Scholar 

  22. Thomsen, S.F., et al., Intake of paracetamol and risk of asthma in adults. J Asthma, 2008. 45(8): p. 675–6.

    CAS  PubMed  Google Scholar 

  23. Farquhar, H., et al., The role of paracetamol in the pathogenesis of asthma. Clin Exp Allergy, 2010. 40(1): p. 32–41.

    CAS  PubMed  Google Scholar 

  24. Decramer, M., et al., Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary ­disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-­controlled trial. Lancet, 2005. 365(9470): p. 1552–60.

    CAS  PubMed  Google Scholar 

  25. Rogers, D.F., Mucoactive agents for airway mucus hypersecretory diseases. Respir Care, 2007. 52(9): p. 1176–93; discussion 1193–7.

    Google Scholar 

  26. Sutherland, E.R., J.D. Crapo, and R.P. Bowler, N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease. COPD, 2006. 3(4): p. 195–202.

    PubMed  Google Scholar 

  27. Falliers, C.J. and A. Cato, Controlled trial of bronchodilator-mucolytic aerosols, combined and separate. Ann Allergy, 1978. 40(2): p. 77–83.

    CAS  PubMed  Google Scholar 

  28. Bylin, G., et al., No influence of acetylcysteine on gas exchange and spirometry in chronic asthma. Eur J Respir Dis, 1987. 71(2): p. 102–7.

    CAS  PubMed  Google Scholar 

  29. Ho, S.W. and L.J. Beilin, Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases. Br Med J (Clin Res Ed), 1983. 287(6396): p. 876–7.

    CAS  Google Scholar 

  30. Mant, T.G., et al., Adverse reactions to acetylcysteine and effects of overdose. Br Med J (Clin Res Ed), 1984. 289(6439): p. 217–9.

    CAS  Google Scholar 

  31. Zyoud, S.H., et al., Incidence of adverse drug reactions induced by N-acetylcysteine in patients with acetaminophen overdose. Hum Exp Toxicol, 2010. 29(3): p. 153–60.

    CAS  PubMed  Google Scholar 

  32. Sandilands, E.A. and D.N. Bateman, Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila), 2009. 47(2): p. 81–8.

    CAS  Google Scholar 

  33. Schmidt, L.E. and K. Dalhoff, Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol, 2001. 51(1): p. 87–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Wolff, A.J. and A.E. O’Donnell, Pulmonary effects of illicit drug use. Clin Chest Med, 2004. 25(1): p. 203–16.

    PubMed  Google Scholar 

  35. Han, B., J.C. Gfroerer, and J.D. Colliver, Associations between duration of illicit drug use and health conditions: results from the 2005–2007 national surveys on drug use and health. Ann Epidemiol, 2010. 20(4): p. 289–97.

    PubMed  Google Scholar 

  36. Weitzman, J.B., N.F. Kanarek, and J.E. Smialek, Medical examiner asthma death autopsies: a distinct subgroup of asthma deaths with implications for public health preventive strategies. Arch Pathol Lab Med, 1998. 122(8): p. 691–9.

    CAS  PubMed  Google Scholar 

  37. Levenson, T., et al., Asthma deaths confounded by substance abuse. An assessment of fatal asthma. Chest, 1996. 110(3): p. 604–10.

    CAS  PubMed  Google Scholar 

  38. Merigian, K. and K. Blaho, The role of pharmacology and forensics in the death of an asthmatic. J Anal Toxicol, 1995. 19(6): p. 522–8.

    CAS  PubMed  Google Scholar 

  39. Waldbott, G.L., Asthma due to a local anesthetic. J Am Med Assoc, 1932. 99(23): p. 1942.

    Google Scholar 

  40. Weiss, K.B., P.J. Gergen, and E.F. Crain, Inner-city asthma. The epidemiology of an emerging US public health concern. Chest, 1992. 101(6 Suppl): p. 362 S–367 S.

    CAS  PubMed  Google Scholar 

  41. Greenberger, P.A., T.P. Miller, and B. Lifschultz, Circumstances surrounding deaths from asthma in Cook County (Chicago) Illinois. Allergy Proc, 1993. 14(5): p. 321–6.

    CAS  PubMed  Google Scholar 

  42. Osborn, H.H., et al., New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med, 1997. 4(7): p. 689–92.

    CAS  PubMed  Google Scholar 

  43. Panacek, E.A., et al., Is unexplained bronchospasm associated with the use of cocaine (abstract)? Ann Emerg Med, 1991. 20 (suppl): p. 488–489.

    Google Scholar 

  44. Rome, L.A., et al., Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest, 2000. 117(5): p. 1324–9.

    CAS  PubMed  Google Scholar 

  45. Rubin, R.B. and J. Neugarten, Cocaine-associated asthma. Am J Med, 1990. 88(4): p. 438–9.

    CAS  PubMed  Google Scholar 

  46. Rebhun, J., Association of asthma and freebase smoking. Ann Allergy, 1988. 60(4): p. 339–42.

    CAS  PubMed  Google Scholar 

  47. Rao, A.N., P.G. Polos, and F.A. Walther, Crack abuse and asthma: a fatal combination. N Y State J Med, 1990. 90(10): p. 511–2.

    CAS  PubMed  Google Scholar 

  48. Levine, M., et al., The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest, 2005. 128(4): p. 1951–7.

    PubMed  Google Scholar 

  49. Averbach, M., K.K. Casey, and E. Frank, Near-fatal status asthmaticus induced by nasal insufflation of cocaine. South Med J, 1996. 89(3): p. 340–1.

    CAS  PubMed  Google Scholar 

  50. Meisels, I.S. and J. Loke, The pulmonary effects of free-base cocaine: a review. Cleve Clin J Med, 1993. 60(4): p. 325–9.

    CAS  PubMed  Google Scholar 

  51. Dean, N.C., et al., Pulmonary function in heavy users of ‘freebase’ cocaine (abstr) Am Rev Respir Dis, 1988. 137 S: p. 489.

    Google Scholar 

  52. Weiss, R.D., et al., Pulmonary dysfunction in cocaine smokers. Am J Psychiatry, 1981. 138(8): p. 1110–2.

    CAS  PubMed  Google Scholar 

  53. Weiss, R.D., et al., Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. Drug Alcohol Depend, 1987. 19(3): p. 271–6.

    CAS  PubMed  Google Scholar 

  54. Susskind, H., et al., Increased lung permeability following long-term use of free-base cocaine (crack). Chest, 1991. 100(4): p. 903–9.

    CAS  PubMed  Google Scholar 

  55. Itkonen, J., S. Schnoll, and J. Glassroth, Pulmonary dysfunction in ‘freebase’ cocaine users. Arch Intern Med, 1984. 144(11): p. 2195–7.

    CAS  PubMed  Google Scholar 

  56. Tashkin, D.P., Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med, 2001. 7(2): p. 43–61.

    CAS  PubMed  Google Scholar 

  57. Tashkin, D.P., et al., Acute effects of inhaled and i.v. cocaine on airway dynamics. Chest, 1996. 110(4): p. 904–10.

    CAS  PubMed  Google Scholar 

  58. Kissner, D.G., et al., Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis, 1987. 136(5): p. 1250–2.

    CAS  PubMed  Google Scholar 

  59. Kikuchi, Y., et al., Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med, 1994. 330(19): p. 1329–34.

    CAS  PubMed  Google Scholar 

  60. Zaas, D., et al., An uncommon mimic of an acute asthma exacerbation. Chest, 2002. 121(5): p. 1707–9.

    PubMed  Google Scholar 

  61. Dowling, G.P., E.T. McDonough, III, and R.O. Bost, ‘Eve’ and ‘Ecstasy’. A report of five deaths associated with the use of MDEA and MDMA. JAMA, 1987. 257(12): p. 1615–7.

    CAS  PubMed  Google Scholar 

  62. Saito, T., et al., Determination of chronic methamphetamine abuse by hair analysis. Forensic Sci Int, 2000. 112(1): p. 65–71.

    CAS  PubMed  Google Scholar 

  63. Schmidt, R.A., et al., Panlobular emphysema in young intravenous Ritalin abusers. Am Rev Respir Dis, 1991. 143(3): p. 649–56.

    CAS  PubMed  Google Scholar 

  64. Sherman, C.B., L.D. Hudson, and D.J. Pierson, Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest, 1987. 92(6): p. 1085–7.

    CAS  PubMed  Google Scholar 

  65. del los Santos-Sastre, S., F. Capote-Gil, and A. Gonzales-Castro, Airway obstruction and heroin ­inhalation. Lancet, 1986. 2(8516): p. 1158.

    Google Scholar 

  66. Oliver, R.M., Bronchospasm and heroin inhalation. Lancet, 1986. 1(8486): p. 915.

    CAS  PubMed  Google Scholar 

  67. Anderson, K., Bronchospasm and intravenous street heroin. Lancet, 1986. 1(8491): p. 1208.

    CAS  PubMed  Google Scholar 

  68. Hughes, S. and P.M. Calverley, Heroin inhalation and asthma. BMJ, 1988. 297(6662): p. 1511–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Sapira, J.D., The narcotic addict as a medical patient. Am J Med, 1968. 45(4): p. 555–88.

    CAS  PubMed  Google Scholar 

  70. Ghodse, A.H. and J.S. Myles, Asthma in opiate addicts. J Psychosom Res, 1987. 31(1): p. 41–4.

    CAS  PubMed  Google Scholar 

  71. Cruz, R., et al., Pulmonary manifestations of inhaled street drugs. Heart Lung, 1998. 27(5): p. 297–305; quiz 306–7.

    CAS  Google Scholar 

  72. Brander, P.E. and P. Tukiainen, Acute eosinophilic pneumonia in a heroin smoker. Eur Respir J, 1993. 6(5): p. 750–2.

    CAS  PubMed  Google Scholar 

  73. Cygan, J., M. Trunsky, and T. Corbridge, Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest, 2000. 117(1): p. 272–5.

    CAS  PubMed  Google Scholar 

  74. Spiritus, E.M., A.F. Wilson, and R.A. Berke, Lung scans in asymptomatic heroin addicts. Am Rev Respir Dis, 1973. 108(4): p. 994–6.

    CAS  PubMed  Google Scholar 

  75. Camargo, G. and C. Colp, Pulmonary function studies in ex-heroin users. Chest, 1975. 67(3): p. 331–4.

    CAS  PubMed  Google Scholar 

  76. Overland, E.S., A.J. Nolan, and P.C. Hopewell, Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities. Am J Med, 1980. 68(2): p. 231–7.

    CAS  PubMed  Google Scholar 

  77. Krantz, A.J., et al., Heroin insufflation as a trigger for patients with life-threatening asthma. Chest, 2003. 123(2): p. 510–7.

    PubMed  Google Scholar 

  78. Eschenbacher, W.L., et al., Morphine sulfate inhibits bronchoconstriction in subjects with mild asthma whose responses are inhibited by atropine. Am Rev Respir Dis, 1984. 130(3): p. 363–7.

    CAS  PubMed  Google Scholar 

  79. Mestiri, M., et al., Effect of inhaled morphine on the bronchial response to isocapnic hyperventilation in patients with allergic asthma. Eur J Clin Pharmacol, 1991. 41(6): p. 621.

    CAS  PubMed  Google Scholar 

  80. Field, P.I., et al., Evidence for opioid modulation and generation of prostaglandins in sulphur dioxide (SO)2-induced bronchoconstriction. Thorax, 1996. 51(2): p. 159–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Ulinski, S., C. Palczynski, and P. Gorski, Occupational rhinitis and bronchial asthma due to morphine: evidence from inhalational and nasal challenges. Allergy, 1996. 51(12): p. 914–8.

    CAS  PubMed  Google Scholar 

  82. Biagini, R.E., et al., Antibodies to morphine in workers exposed to opiates at a narcotics manufacturing facility and evidence for similar antibodies in heroin abusers. Life Sci, 1990. 47(10): p. 897–908.

    CAS  PubMed  Google Scholar 

  83. Tashkin, D.P., et al., Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol, 2002. 42(11 Suppl): p. 71 S–81 S.

    CAS  PubMed  Google Scholar 

  84. Tashkin, D.P., B.J. Shapiro, and I.M. Frank, Acute effects of smoked marijuana and oral delta9-­tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis, 1974. 109(4): p. 420–8.

    CAS  PubMed  Google Scholar 

  85. Tashkin, D.P., et al., Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis, 1987. 135(1): p. 209–16.

    CAS  PubMed  Google Scholar 

  86. Bloom, J.W., et al., Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed), 1987. 295(6612): p. 1516–8.

    CAS  Google Scholar 

  87. Taylor, D.R., et al., The respiratory effects of cannabis dependence in young adults. Addiction, 2000. 95(11): p. 1669–77.

    CAS  PubMed  Google Scholar 

  88. Friedman, H., et al., Marijuana, receptors and immunomodulation. Adv Exp Med Biol, 1995. 373: p. 103–13.

    CAS  PubMed  Google Scholar 

  89. Specter, S.C., et al., Marijuana effects on immunity: suppression of human natural killer cell activity of delta-9-tetrahydrocannabinol. Int J Immunopharmacol, 1986. 8(7): p. 741–5.

    CAS  PubMed  Google Scholar 

  90. Anonymous. Tobacco use and usual source of cigarettes among high school students--United States, 1995. MMWR Morb Mortal Wkly Rep, 1996. 45(20): p. 413–8.

    Google Scholar 

  91. Anonymous. Prevalence of cigarette use among 14 racial/ethnic populations--United States, 1999–2001. MMWR Morb Mortal Wkly Rep, 2004. 53(3): p. 49–52.

    Google Scholar 

  92. Anon. Cigarette smoking and health. American Thoracic Society. Am J Respir Crit Care Med, 1996. 153(2): p. 861–5.

    Google Scholar 

  93. Benowitz, N.L., Nicotine addiction. N Engl J Med, 2010. 362(24): p. 2295–303.

    CAS  PubMed  PubMed Central  Google Scholar 

  94. Willers, S., E. Svenonius, and G. Skarping, Passive smoking and childhood asthma. Urinary cotinine levels in children with asthma and in referents. Allergy, 1991. 46(5): p. 330–4.

    CAS  PubMed  Google Scholar 

  95. Cunningham, J., D.W. Dockery, and F.E. Speizer, Maternal smoking during pregnancy as a predictor of lung function in children. Am J Epidemiol, 1994. 139(12): p. 1139–52.

    CAS  PubMed  Google Scholar 

  96. Weiss, S.T., Environmental risk factors in childhood asthma. Clin Exp Allergy, 1998. 28 Suppl 5: p. 29–34; discussion 50–1.

    PubMed  Google Scholar 

  97. Annesi-Maesano, I., et al., Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern? Clin Exp Allergy, 2004. 34(7): p. 1017–23.

    CAS  PubMed  Google Scholar 

  98. Jang, A.S., et al., The effect of passive smoking on asthma symptoms,atopy,and airway hyperresponsiveness in schoolchildren. J Korean Med Sci, 2004. 19(2): p. 214–7.

    PubMed  PubMed Central  Google Scholar 

  99. Janson, C., The effect of passive smoking on respiratory health in children and adults. Int J Tuberc Lung Dis, 2004. 8(5): p. 510–6.

    CAS  PubMed  Google Scholar 

  100. LeSon, S. and M.E. Gershwin, Risk factors for asthmatic patients requiring intubation. I. Observations in children. J Asthma, 1995. 32(4): p. 285–94.

    CAS  PubMed  Google Scholar 

  101. Eisner, M.D., et al., Environmental tobacco smoke and adult asthma. The impact of changing exposure status on health outcomes. Am J Respir Crit Care Med, 1998. 158(1): p. 170–5.

    CAS  PubMed  Google Scholar 

  102. Flodin, U., et al., An epidemiologic study of bronchial asthma and smoking. Epidemiology, 1995. 6(5): p. 503–5.

    CAS  PubMed  Google Scholar 

  103. White, J.R. and H.F. Froeb, Small-airways dysfunction in nonsmokers chronically exposed to tobacco smoke. N Engl J Med, 1980. 302(13): p. 720–3.

    CAS  PubMed  Google Scholar 

  104. Schwartz, J., K.L. Timonen, and J. Pekkanen, Respiratory effects of environmental tobacco smoke in a panel study of asthmatic and symptomatic children. Am J Respir Crit Care Med, 2000. 161(3 Pt 1): p. 802–6.

    CAS  PubMed  Google Scholar 

  105. Lubman, D.I., M. Yucel, and A.J. Lawrence, Inhalant abuse among adolescents: neurobiological considerations. Br J Pharmacol, 2008. 154(2): p. 316–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  106. Chadwick, O., et al., Neuropsychological consequences of volatile substance abuse: a population based study of secondary school pupils. BMJ, 1989. 298(6689): p. 1679–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  107. Wu, L.T., D.J. Pilowsky, and W.E. Schlenger, Inhalant abuse and dependence among adolescents in the United States. J Am Acad Child Adolesc Psychiatry, 2004. 43(10): p. 1206–14.

    PubMed  PubMed Central  Google Scholar 

  108. Schikler, K.N., et al., Solvent abuse associated pulmonary abnormalities. Adv Alcohol Subst Abuse, 1984. 3(3): p. 75–81.

    CAS  PubMed  Google Scholar 

  109. Meredith, T.J., et al., Diagnosis and treatment of acute poisoning with volatile substances. Hum Toxicol, 1989. 8(4): p. 277–286.

    CAS  PubMed  Google Scholar 

  110. Cartwright, T.R., E.D. Brown, and R.E. Brashear, Pulmonary infiltrates following butane ‘fire-breathing’. Arch Intern Med, 1983. 143(10): p. 2007–8.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine and Department of Emergency Medicine, University of California at Davis, Sacramento, CA, USA

    Timothy E. Albertson MD, MPH, PhD & Nicholas J. Kenyon MD, MAS

  2. VA Northern California Health Care System, Mather, CA, USA

    Timothy E. Albertson MD, MPH, PhD, Kelly P. Owen MD & Nicholas J. Kenyon MD, MAS

  3. Department of Emergency Medicine, University of California at Davis, Sacramento Medical Center, Sacramento, CA, USA

    Kelly P. Owen MD

  4. Department of Emergency Medicine, University of California at Davis, Sacramento, CA, USA

    Mark E. Sutter MD

  5. UC Davis Center for Comparative Respiratory Biology and Medicine, Davis, CA, USA

    Nicholas J. Kenyon MD, MAS

Authors
  1. Timothy E. Albertson MD, MPH, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kelly P. Owen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark E. Sutter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicholas J. Kenyon MD, MAS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy E. Albertson MD, MPH, PhD .

Editor information

Editors and Affiliations

  1. School of Medicine, Division of Rheumatology, Allergy &, University of California, Davis, Davis, 95616, California, USA

    M. Eric Gershwin

  2. , Pulmonary and Critical Care, UC Davis Medical Group, J St. 2825, Davis, 95816, California, USA

    Timothy E. Albertson

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Albertson, T.E., Owen, K.P., Sutter, M.E., Kenyon, N.J. (2012). How Drugs Including Recreational Drugs Affect Asthma. In: Gershwin, M., Albertson, T. (eds) Bronchial Asthma. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6836-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6836-4_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-6835-7

  • Online ISBN: 978-1-4419-6836-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation